A recent ASK Uveal Melanoma webinar is now available to watch on-demand, delivering education on the clinical significance of this rare disease that poses a significant challenge for clinicians.
Titled ‘Staring you straight in the eye: uveal melanoma?’, this free expert-led session brings together international specialists in ophthalmic pathology, ophthalmology and medical oncology to explore the recognition, diagnosis and management of this condition.
Although rare, uveal melanoma is the most common primary intraocular malignant tumour in adults. It requires timely recognition, appropriate referral and specialist multidisciplinary care.
Uveal melanoma webinar details
This webinar provides a focused overview of uveal melanoma, supporting you to understand how the disease develops, presents and is managed in clinical practice.
During the session, the expert faculty explore:
How uveal melanoma develops and presents
Key risk factors and molecular characteristics
Signs and symptoms, including changes in vision
Diagnostic imaging, assessment and staging
Current treatment and surveillance approaches
Multidisciplinary management and emerging research.
The webinar features insights from Professor Sarah Coupland, ophthalmic pathology co-lead at Liverpool Clinical Laboratories, Royal Liverpool University Hospital, UK; Dr Sophie Piperno-Neumann, medical oncologist at the leading French cancer treatment and research centre, the Curie Institute, in Paris, France; and Professor Antonia M. Joussen, chair of ophthalmology and vitreoretinal surgeon at Charité – University Medicine Berlin, Germany.
Watch the webinar on demand today.
You can earn 1 CE/CPD credit (pending CME accreditation), and the webinar forms part of the ASK Uveal Melanoma education programme, designed to support healthcare professionals in improving their attitude, skills and knowledge around this rare disease.
This is an independent activity supported by educational grant funding from Delcath Systems Inc. Learners may participate in this educational activity free of charge.